Xbiotech Inc (XBIT)

Trade XBIT now with
1/21/2021 9:55:53 AM Stock Alert: XBiotech UP 6%
9/21/2020 8:37:37 AM XBiotech Says Developing New Breakthrough Candidate Therapy It Calls FLUVID
8/24/2020 10:24:52 AM Stock Alert: XBiotech Jumps 12%
8/24/2020 8:30:28 AM XBiotech: FDA Issues Emergency Use Authorization For COVID-19 Convalescent Plasma
8/17/2020 8:23:53 AM XBiotech Says Identified True Human Antibodies That Could Be Used As COVID-19 Candidate Therapy
1/14/2020 8:41:57 AM XBiotech Commences Modified Dutch Auction Tender Offer To Purchase Up To $420 Mln Of Common Shares
12/30/2019 4:26:31 PM XBiotech Closes On Sale Of True Human Antibody Bermekimab To Janssen
7/9/2019 8:15:21 AM XBiotech: MRC Funds Phase 2 Multi-Center Study Of Bermekimab
3/5/2019 8:30:59 AM XBiotech Releases Findings For Phase 2 Clinical Study For Bermekimab
12/3/2018 8:16:14 AM XBiotech Announces Successful GMP Audit By Eurofins Amatsigroup
10/26/2018 8:20:26 AM XBiotech Says Awarded 11 New Patents Or Patent Allowances In Q3
9/26/2018 8:06:50 AM XBiotech Reports Granting Of European Patent For Treatment Of Inflammatory Skin Diseases
9/24/2018 8:31:23 AM XBiotech Completes F U.S. Enrollment In Phase 2 Study Evaluating Bermekimab In Patients With Hidradenitis Suppurativa